Exact Sciences Stock - Analyst consensus and valuation snapshot

Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/22/2026, 02:45 UTC. Details in the imprint.

Exact Sciences (US30063P1057) is a US-based cancer diagnostics specialist whose stock remains a focus for growth-oriented healthcare investors. With no fresh company filings or major news in the past 24 hours, the key picture today comes from the current analyst consensus on earnings and valuation.

What analysts currently expect

Exact Sciences is covered by a broad group of Wall Street banks and boutiques that publish regular earnings estimates and price targets. Consensus data from several broker aggregators still show a predominance of Buy and Overweight ratings on the stock.

For the current fiscal year, analysts on average expect Exact Sciences to continue growing revenue at a double-digit percentage rate, while the company remains close to break-even on an adjusted earnings basis. Many houses emphasize the sizable addressable market in colorectal and multi-cancer screening as a medium-term driver.

How the consensus has shifted

Compared with expectations at the start of the year, the analyst consensus on Exact Sciences has become somewhat more cautious. Some brokers have trimmed their price targets in recent months, reflecting a higher discount rate and a more selective stance on loss-making growth names.

Even so, the average 12-month price target for Exact Sciences remains above the current share price, implying upside from today's level according to recent consensus compilations. Rating distributions show only a small minority of Sell recommendations, with most strategists either positive or neutral on the name.

What the company sells

Exact Sciences generates most of its revenue from cancer screening tests such as Cologuard, a stool-based DNA test for colorectal cancer that can be used at home. The group also offers precision oncology solutions that analyze tumor genetics to help oncologists refine treatment decisions.

Where the stock trades today

The shares of Exact Sciences (US30063P1057) trade on Nasdaq at $EXAS_PRICE as of 06/22/2026, 02:45 UTC.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.